$YHGJ
YUNHONG GREEN CTI LTD. Stock $yhgj

$yhgj Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017254 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$4.059M	$5.051M
YoY Change	-8.13%	-12.87%
Cost Of Revenue	$3.545M	$3.924M
YoY Change	-1.94%	-17.53%
Gross Profit	$514.0K	$1.127M
YoY Change	-35.99%	8.47%
Gross Profit Margin	12.66%	22.31%
Selling, General & Admin	$689.0K	$993.0K
YoY Change	-33.24%	13.49%
% of Gross Profit	134.05%	88.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$71.00K	$80.00K
YoY Change	-26.8%	-18.37%
% of Gross Profit	13.81%	7.1%
Operating Expenses	$804.0K	$1.115M
YoY Change	-27.5%	5.39%
Operating Profit	-$290.0K	$12.00K
YoY Change	-5.23%	-163.16%
Interest Expense	$155.0K	$142.0K
YoY Change	42.2%	47.92%
% of Operating Profit		1183.33%
Other Income/Expense, Net	$141.0K	$384.0K
YoY Change	-251.61%	-19300.0%
Pretax Income	-$149.0K	$396.0K
YoY Change	-62.66%	-1985.71%
Income Tax
% Of Pretax Income
Net Earnings	-$149.0K	$23.00M
YoY Change	-62.66%	-109623.81%
Net Earnings / Revenue	-3.67%	455.36%
Basic Earnings Per Share	-$0.01	$0.02
Diluted Earnings Per Share	-$0.01	$0.02
COMMON SHARES
Basic Shares Outstanding	19.97M shares	19.97M shares
Diluted Shares Outstanding	20.03M shares	17.69M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.0K	$130.0K
YoY Change	85.19%	-37.5%
Cash & Equivalents	$100.0K	$130.0K
Short-Term Investments
Other Short-Term Assets	$436.0K	$489.0K
YoY Change	115.84%	103.75%
Inventory	$7.639M	$7.944M
Prepaid Expenses	$436.0K	$489.0K
Receivables	$2.959M	$3.344M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$11.13M	$11.91M
YoY Change	-5.42%	-7.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$865.0K	$898.0K
YoY Change	-16.91%	-16.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.493M	$4.655M
YoY Change	-16.18%	-13.04%
TOTAL ASSETS
Total Short-Term Assets	$11.13M	$11.91M
Total Long-Term Assets	$4.493M	$4.655M
Total Assets	$15.63M	$16.56M
YoY Change	-8.78%	-9.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$982.0K	$1.278M
YoY Change	-51.39%	-45.55%
Accrued Expenses	$1.014M	$1.382M
YoY Change	90.96%	184.95%
Deferred Revenue
YoY Change
Short-Term Debt	$4.288M	$4.284M
YoY Change	-10.33%	-16.94%
Long-Term Debt Due	$1.826M	$1.826M
YoY Change	664.02%	697.38%
Total Short-Term Liabilities	$8.629M	$9.288M
YoY Change	6.9%	6.53%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$3.109M	$3.239M
YoY Change	-14.31%	-14.24%
Total Long-Term Liabilities	$3.109M	$3.239M
YoY Change	-41.75%	-40.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.629M	$9.288M
Total Long-Term Liabilities	$3.109M	$3.239M
Total Liabilities	$11.74M	$12.53M
YoY Change	-12.46%	-11.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.88M	-$23.72M
YoY Change	3.47%	4.62%
Common Stock	$21.28M	$27.92M
YoY Change	14.78%	49.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$161.0K	$161.0K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$3.889M	$4.035M
YoY Change
Total Liabilities & Shareholders Equity	$15.63M	$16.56M
YoY Change	-8.78%	-9.3%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$149.0K	$23.00M
YoY Change	-62.66%	-109623.81%
Depreciation, Depletion And Amortization	$71.00K	$80.00K
YoY Change	-26.8%	-18.37%
Cash From Operating Activities	$8.000K	-$1.369M
YoY Change	-97.34%	-68550.0%
INVESTING ACTIVITIES
Capital Expenditures	$38.00K	$56.00K
YoY Change	-148.1%	-473.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$38.00K	-$56.00K
YoY Change	-51.9%	273.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$45.00K
YoY Change
Cash From Financing Activities	0.000	$1.409M
YoY Change	-100.0%	809.03%
NET CHANGE
Cash From Operating Activities	8.000K	-$1.369M
Cash From Investing Activities	-38.00K	-$56.00K
Cash From Financing Activities	0.000	$1.409M
Net Change In Cash	-30.00K	-$16.00K
YoY Change	-80.52%	-111.27%
FREE CASH FLOW
Cash From Operating Activities	$8.000K	-$1.369M
Capital Expenditures	$38.00K	$56.00K
Free Cash Flow	-$30.00K	-$1.425M
YoY Change	-107.89%	-8482.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	CTIB	Series B Convertible Preferred Stock Modification SeriesBConvertiblePreferredStockModification		usd
CY2023Q1	CTIB	Accrued Deemed Dividends One AccruedDeemedDividendsOne		usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent		usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001042187
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax		usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022Q1	CTIB	Accrued Deemed Dividends Three AccruedDeemedDividendsThree		usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q1	CTIB	Conversion Of Notes And Deposits Into Common Stock ConversionOfNotesAndDepositsIntoCommonStock		usd
CY2022Q1	CTIB	Accrued Deemed Dividends AccruedDeemedDividends		usd
CY2022Q1	CTIB	Accrued Deemed Dividends One AccruedDeemedDividendsOne		usd
CY2022Q1	CTIB	Accrued Deemed Dividends Two AccruedDeemedDividendsTwo		usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	164000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-23115
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	YUNHONG CTI LTD.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IL
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-2848943
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	22160 N. Pepper Road
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Barrington
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60010
CY2023Q1	dei	City Area Code CityAreaCode	(847)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	382-1000
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, no par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	CTIB
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19971755	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	130000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	146000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3344000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1618000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	7944000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8325000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	489000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	389000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	11907000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10478000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17723000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17723000	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2084000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2084000	usd
CY2023Q1	CTIB	Intellectual Property Gross IntellectualPropertyGross	783000	usd
CY2022Q4	CTIB	Intellectual Property Gross IntellectualPropertyGross	783000	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	39000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	39000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	519000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	519000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	108000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21312000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21256000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20414000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20334000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	898000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	922000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3757000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3882000	usd
CY2023Q1	CTIB	Assets Noncurrent Excluding Property Plant And Equipment AssetsNoncurrentExcludingPropertyPlantAndEquipment	3757000	usd
CY2022Q4	CTIB	Assets Noncurrent Excluding Property Plant And Equipment AssetsNoncurrentExcludingPropertyPlantAndEquipment	3882000	usd
CY2023Q1	us-gaap	Assets Assets	16562000	usd
CY2022Q4	us-gaap	Assets Assets	15282000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1278000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1313000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4284000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2878000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	540000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	289000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	518000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	518000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1382000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2480000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9288000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7478000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	427000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3239000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3364000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3239000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5058000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	12527000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12536000	usd
CY2023Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	170000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	170000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	170000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	170000	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1851000	usd
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20015413	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16102749	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19971755	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16059991	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	21283000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	21283000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6637000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3895000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23724000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24122000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	43658	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	43658	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	161000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	161000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4035000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2746000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16562000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15282000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5051000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5797000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3924000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4758000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1127000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1039000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	961000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	837000	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	32000	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	38000	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	122000	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	183000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1115000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1058000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	12000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-19000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	142000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	96000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	526000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	94000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	384000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	396000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	396000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-21000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	396000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-21000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	396000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21000	usd
CY2023Q1	CTIB	Deemed Dividends On Preferred Stock And Amortization Of Beneficial Conversion Feature DeemedDividendsOnPreferredStockAndAmortizationOfBeneficialConversionFeature	11000	usd
CY2022Q1	CTIB	Deemed Dividends On Preferred Stock And Amortization Of Beneficial Conversion Feature DeemedDividendsOnPreferredStockAndAmortizationOfBeneficialConversionFeature	202000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	385000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-223000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17689552	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5900639	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17689552	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5900639	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	396000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-21000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	80000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	98000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	31000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1726000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-125000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-381000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	620000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	100000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-339000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-35000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	215000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-372000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-167000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1369000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	56000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1409000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	155000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1409000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	155000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	142000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	146000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	66000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	130000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	208000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	118000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	78000	usd
CY2023Q1	CTIB	Accrued Dividend On Preferred Stock AccruedDividendOnPreferredStock	11000	usd
CY2022Q1	CTIB	Accrued Dividend On Preferred Stock AccruedDividendOnPreferredStock	202000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	747000	usd
CY2023Q1	CTIB	Conversion Of Notes And Deposits Into Common Stock ConversionOfNotesAndDepositsIntoCommonStock	885000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4051000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-21000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	4061000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2746000	usd
CY2023Q1	CTIB	Common Stock Issued For Notes Payable And Investor Deposit Value CommonStockIssuedForNotesPayableAndInvestorDepositValue	884000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	396000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4035000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zNE6kk975xvk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zoZVllggTL7l">Reclassification</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the Company’s condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_z6Q6iM7QFIKk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zygOmlbKuEzc">Use of estimates</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include valuation allowances for doubtful accounts and inventory valuation, preferred stock dividends and beneficial conversion features, and assumptions used as inputs in the Black-Scholes option-pricing model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	128000	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	128000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23000000	usd
CY2021Q4	CTIB	Debt Instrument Covenant Tangible Net Worth DebtInstrumentCovenantTangibleNetWorth	4000000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	4284000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	2878000	usd
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	172000	usd
CY2022Q4	CTIB	Notes Payable Interest NotesPayableInterest	0.03	pure
CY2023Q1	CTIB	Common Stock Rate Percentage CommonStockRatePercentage	0.84	pure
CY2023Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	900000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1800000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	792660	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	792660	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	597500	shares
CY2020	CTIB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Cashless Exchange ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCashlessExchange	391308	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	195160	shares
CY2021Q1	CTIB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Cashless Exchange ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCashlessExchange	103104	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.75
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.68	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.68	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.67	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.67	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.42	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0165	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	128000	shares
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1374000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1457000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2631000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2513000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3939000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4355000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	7944000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8325000	usd
CY2023Q1	CTIB	Number Of Major Customers NumberOfMajorCustomers	2	customers
CY2022Q1	CTIB	Number Of Major Customers NumberOfMajorCustomers	2	customers

Files In Submission

Name	View Source	Status
ctib-20230331_lab.xml	Edgar Link	unprocessable
0001493152-23-017254-index-headers.html	Edgar Link	pending
0001493152-23-017254-index.html	Edgar Link	pending
0001493152-23-017254.txt	Edgar Link	pending
0001493152-23-017254-xbrl.zip	Edgar Link	pending
ctib-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
ctib-20230331_cal.xml	Edgar Link	unprocessable
ctib-20230331_def.xml	Edgar Link	unprocessable
ctib-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$YHGJ
YUNHONG GREEN CTI LTD. Stock $yhgj

2023 Q2 Form 10-Q Financial Statement

#000149315223017254 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YHGJ YUNHONG GREEN CTI LTD. Stock $yhgj

2023 Q2 Form 10-Q Financial Statement

#000149315223017254 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YHGJ
YUNHONG GREEN CTI LTD. Stock $yhgj